Hypertrophic Cardiomyopathy Pilot Study



Status:Active, not recruiting
Conditions:High Cholesterol, Peripheral Vascular Disease, Cardiology, Cardiology, Orthopedic
Therapuetic Areas:Cardiology / Vascular Diseases, Orthopedics / Podiatry
Healthy:No
Age Range:18 - 99
Updated:8/23/2018
Start Date:September 2016
End Date:June 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Pilot Observational Case-control Study of the Electrical Heterogeneity in Patients With Hypertrophic Cardiomyopathy and High Arrhythmic Risk

This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in
comparison to patients with well-understood arrhythmogenic substrate (ischemic
cardiomyopathy), as well as to individuals free from arrhythmogenic substrate


Inclusion Criteria:

- Diagnosed HCM

- Documented history of sustained ventricular tachyarrhythmia or resuscitated sudden
cardiac arrest

- Maximal left ventricular wall thickness of > 30mm

- Extensive fibrosis on cardiac MRI (>15% of total myocardial volume)

- >7.5%/5-year risk of sudden cardiac death as determined by HCM risk-SCD

Exclusion Criteria:

- age < 18 years

- Pregnancy

- Atrial Fibrillation
We found this trial at
1
site
Oregon Health and Science University
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials